Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $60.41 Analyst target: $57.56 Upside: -4.72%
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.
See the full interactive analysis & chart →Informational only — not investment advice.